Evidence map›Paper›PMID 40950123›Full record

ArticlebioRxiv : the preprint server for biology2025

Evaluation of toxicological mechanisms of ochratoxin-A in human primary proximal tubule epithelial cells.

Anish Mahadeo, Theo K Bammler, James MacDonald, Angela R Zheng, Catherine K Yeung, Jonathan Himmelfarb, Edward J Kelly

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anish MahadeoDepartment of Pharmaceutics, University of Washington, H-272 Health Sciences Building, Box 357610, Seattle, Washington 98195.
Theo K BammlerDepartment of Environmental and Occupational Health Sciences, University of Washington, Box 354695, Seattle, WA 98195-7234.
James MacDonaldDepartment of Environmental and Occupational Health Sciences, University of Washington, Box 354695, Seattle, WA 98195-7234.
Angela R ZhengDepartment of Pharmaceutics, University of Washington, H-272 Health Sciences Building, Box 357610, Seattle, Washington 98195.
Catherine K YeungDepartment of Pharmacy, University of Washington, Box 357630, H375 Health Science Building, Seattle WA 98195-7630.
Jonathan HimmelfarbDepartment of Medicine, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029-5674.
Edward J KellyDepartment of Pharmaceutics, University of Washington, H-272 Health Sciences Building, Box 357610, Seattle, Washington 98195.

Funding

XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI Nicole Ann Errett · 1995 to 2026
$42.5M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
A Microphysiological System for Kidney Disease Modeling and Drug Efficacy TestingUG3TR002158 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2017 to 2018
$2.9M
CKDu and Ochratoxin-A: risk assessment studies in a microphysiological systemR21ES031359 · NIEHS · UNIVERSITY OF WASHINGTON · PI KELLY, EDWARD J · 2020 to 2021
$404k
NCATS NIH HHS UG3 TR002158NIDDK NIH HHS P30 DK017047NIEHS NIH HHS P30 ES007033NIEHS NIH HHS R21 ES031359
6 · The paper itself

Abstract

Ochratoxin-A (OTA) is a ubiquitous mycotoxin contaminant in food products and a known nephrotoxin. OTA is hypothesized to be a potential environmental agent causing chronic kidney disease of unknown etiology (CKDu), however the mechanism of OTA toxicity in the human kidney remains elusive. This study aims to elucidate OTA-induced molecular toxicological pathways using primary human proximal tubule epithelial cells (PTECs). We demonstrated that exposure to OTA (10 μM) induces over 7000 differentially expressed genes, including key regulators of mitochondrial fission and fusion. This was confirmed at the cellular level by confocal microscopy, where a breakdown of the mitochondrial network was observed at 100 nM OTA. Crucially, OTA was found to significantly induce reactive oxygen species (mROS) and inhibit basal mitochondrial oxidative phosphorylation as well as glycolysis through measurements of oxygen consumption rate and extracellular acidification, indicating reduced cellular energetics and mitochondrial toxicity. The previously reported downregulation of NRF2 target antioxidant response elements was not able to be recovered with co-administration of NRF2 agonists, sulforaphane or tert-butylhydroquinone, suggesting a possible mechanism of inhibition of NRF2 nuclear translocation or DNA binding. In conclusion, we demonstrate that OTA induces oxidative stress, mitochondrial dysfunction, and reduced ATP production, leading to a senescent-like state in PTECs characteristic of renal disease progression. These findings provide insight into early toxicological endpoints induced by OTA which have been established as pathophysiological changes involved in chronic kidney disease.

Indexed as

Food toxicologymitochondriamycotoxinsnephrotoxicityoxidative stress

Identifiers

PMID40950123
PMCPMC12424944

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.